Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.


Interferon alfacon-1 Product Approval Information - Licensing Action 10/6/97

Proper name: Interferon alfacon-1
Tradename: Infergen
Manufacturer: Amgen, Inc, Thousand Oaks, CA, License #1080
Indication for Use: Treatment of chronic hepatitis C virus (HCV) infection in patients 18 years of age or older with compensated liver disease who have anti-HCV serum antibodies and/or the presence of HCV RNA
Approval Date: 10/6/97
Type of submission: Biologics license application


Approval Letter (PDF)

Label (PDF)


Page Last Updated: 09/30/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English